Trial Profile
A Phase III,Randomized, Double-blind, Propofol-controlled, Parallel-design, Multi-center Study Evaluating The Efficacy and Safety of HSK3486 for Sedation or Anesthesia in Patients Undergoing Colonoscopy and Gastroscopy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Jul 2022
Price :
$35
*
At a glance
- Drugs Cipepofol (Primary) ; Propofol
- Indications Anaesthesia
- Focus Registrational; Therapeutic Use
- Sponsors Sichuan Haisike Pharmaceutical
- 25 Jul 2022 Results assessing compare the deep sedation properties of ciprofol and propofol with a non-inferiority margin of 8% in patients undergoing gastroscopy and colonoscopy, published in the Basic and Clinical Pharmacology and Toxicology.
- 05 Oct 2020 Primary endpoint (Success of colonoscopy procedure) has been met.
- 05 Oct 2020 Results presented at the ANESTHESIOLOGY 2020 Annual Meeting of the American Society of Anesthesiologists.